Covishield booster dose desirable: Serum Institute Chairman

Published On 2021-08-14 07:30 GMT   |   Update On 2021-08-14 13:22 GMT

Pune: The ideal gap between two doses of Covishield is two months and another dose of the vaccine should be taken after six months, the Serum Institute of India (SII) chairman Cyrus Poonawalla said here on Friday. Asked about a report in the medical journal Lancet that antibodies against coronavirus created by Covishield, the vaccine manufactured by the SII, decrease after some time,...

Login or Register to read the full article

Pune: The ideal gap between two doses of Covishield is two months and another dose of the vaccine should be taken after six months, the Serum Institute of India (SII) chairman Cyrus Poonawalla said here on Friday.

Asked about a report in the medical journal Lancet that antibodies against coronavirus created by Covishield, the vaccine manufactured by the SII, decrease after some time, Poonawalla told reporters that it was true that the antibodies decrease, but "memory cells" remain.

"After six months, the antibodies go down and that is why I have taken the third dose. We have given the third dose to our seven to eight thousand SII employees. For those who have completed the second dose, it is my request to take a booster dose (third dose) after six months," he said.

He was speaking at a press conference after receiving the prestigious Lokmanya Tilak award here.

The ideal gap between two doses of Covishield is two months, he said.

"Since there was a shortage of vaccine, the Modi government changed it to three months, but a two-month gap is ideal," Poonawalla said.

He also said that lockdown was not an effective way to deal with the virus.

Read also: Serum Institute anticipates to launch Covovax for adults in October 2021, for children in Q1-2022

"Because if there is no lockdown, the disease will be there in the beginning but later the herd immunity will prevail. Why I prefer herd immunity is because the death rate (due to coronavirus) is very low. Lockdown is a good option when the death rate is high," he said.

In most cases deaths were caused by negligence and delay in reporting the infection to doctors, he claimed.

Read also: Study on mixing of Covaxin, Covishield doses get DCGI okay





Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News